Efficacy and safety of co‐administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia

Single risk factors, such as hypertension and dyslipidemia, can combine to exacerbate the development and severity of cardiovascular disease. Treatment goals may be more effectively achieved if multiple disease factors are targeted with combination treatment. We enrolled 202 patients who were random...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Clin Hypertens (Greenwich)
Prif Awduron: Jin, Xuan, Kim, Moo Hyun, Han, Ki Hoon, Hong, Soon Jun, Ahn, Jeong‐Cheon, Sung, Jung‐Hoon, Cho, Jin‐Man, Lee, Han Cheol, Choi, So‐Yeon, Lee, Kyounghoon, Kim, Woo‐Shik, Rhee, Moo‐Yong, Kim, Ju Han, Hong, Seung Pyo, Yoo, Byung Su, Cho, Eun Joo, Lee, Jae‐Hwan, Kim, Pum‐Joon, Park, Chang‐Gyu, Hyon, Min Su, Shin, Jin Ho, Lee, Sang Hyun, Sung, Ki Chul, Hwang, Jinyong, Kwon, Kihwan, Chae, In‐Ho, Seo, Jeong‐Sook, Kim, Hyungseop, Lee, Hana, Cho, Yoonhwa, Kim, Hyo‐Soo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Combination Therapy
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7692919/
https://ncbi.nlm.nih.gov/pubmed/32937023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13893
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg